KinBio is a rapidly growing biotechnology company based in Rehovot, Israel focusing on developing biopharmaceuticals. Through our experienced team members, KinBio has fostered and developed a large portfolio of technologies for manufacturing generic versions of complex drugs, high quality biosimilars and biologics.
Augmented by our global partnerships, KinBio is specialized in the research, development, manufacturing and global commercialization of biosimilars to treat and prevent diseases across several different therapeutic areas including CNS, inflammation, oncology, and osteoperosis.
Our state of the art cGMP manufacturing plants consists of separate suites for the manufacturing of multi-product biologics bulk drug substances (BDS) and chemical synthesis active pharmaceutical ingredients (APIs) through FDA approved fully fledged sterile drug products plants.
Company Details
- Employees
- 13
- Founded
- -
- Address
- 12, Hamada Street, Rehovot,israel 7670315,israel
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- kinbio.co.il
- Keywords
- Show more similar pages.
- HQ
- Rehovot, Israel
Kinbio Questions
Kinbio's website is kinbio.co.il
Kinbio's LinkedIn profile is https://il.linkedin.com/company/kinbio
Kinbio has
13 employees.
View email and phone details for 13
employees at Kinbio.
Kinbio's industry is
Pharmaceutical Manufacturing
Kinbio's top competitors are
Biomica Ltd.,
Eitan Medical,
Amai Proteins,
Aleph Farms,
Evogene,
Bee-Io Honey Ltd,
Remilk,
Collplant,
Biomx (Nyse: Phge),
Ukko.
Kinbio's categories are Pharmaceutical Manufacturing
Kinbio's founding year is 2019
